MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcvm.2026.1860012

Медицинская библиотека · Frontiers in cardiovascular medicine · 2026

Connective tissue disorders and cardiac arrhythmias: genetic pathways, mechanistic bridges, and clinical implications.

Dreher Luke, Abdul Nabi Hussein, Ibrahim Ramzi, Abdelnabi Mahmoud, Baqal Omar, Kanaan Christopher N, Tan Min Choon, Baudhuin Linnea M, Shamoun Fadi E, El Masry Hicham Z

СтатьяОбзорПеревод в очереди

Аннотация

BACKGROUND

Connective tissue disorders (CTDs) such as Marfan syndrome, Loeys-Dietz syndrome, and Ehlers-Danlos syndromes are traditionally defined by vascular fragility and aortic complications. Increasing evidence, however, demonstrates that CTDs also predispose to atrial and ventricular arrhythmias, often independent of overt cardiomyopathy or severe valvular disease.

CONTENT: This review integrates emerging data on the arrhythmogenic substrates of CTDs. Four mechanistic bridges are emphasized: (1) diffuse myocardial fibrosis driven by dysregulated TGF-β signaling, (2) structural valve and annular abnormalities, particularly mitral valve prolapse and mitral annular disjunction, (3) altered mechanotransduction linking extracellular matrix instability to cytoskeletal and nuclear signaling pathways, and (4) downstream ion-channel and gap-junction remodeling as secondary amplifiers. We outline the genetic architecture underlying these processes, focusing on established CTD-implicated genes in the TGF-β/SMAD pathway, valve and annulus regulators, cytoskeletal and myocyte-coupling proteins, and extracellular matrix components, while incorporating emerging CTD modifiers that expand the spectrum of arrhythmia susceptibility.

SUMMARY: Recognition of CTDs as both vascular and electrical disorders reframes clinical management. Imaging markers such as mitral annular disjunction and diffuse fibrosis, together with targeted ambulatory rhythm monitoring and consideration of genetic context, may improve recognition of higher-risk phenotypes. Therapeutic strategies must balance arrhythmia control with procedural risk in fragile connective tissue substrates.

CONCLUSIONS

By unifying genetic, mechanistic, and clinical insights, this review provides an integrated framework for understanding arrhythmias in CTDs. It underscores the need for prospective registries and genotype-phenotype studies to refine surveillance and prevention strategies.

Для цитирования: Dreher Luke, Abdul Nabi Hussein, Ibrahim Ramzi, Abdelnabi Mahmoud, Baqal Omar, Kanaan Christopher N, Tan Min Choon, Baudhuin Linnea M, Shamoun Fadi E, El Masry Hicham Z. Connective tissue disorders and cardiac arrhythmias: genetic pathways, mechanistic bridges, and clinical implications.. Frontiers in cardiovascular medicine. 2026. DOI: 10.3389/fcvm.2026.1860012.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.